Liraglutide Doses Below 3.0 mg Show Real-World Benefit, but Cost Blocks Half of Patients
A Taiwanese post-marketing surveillance study finds that nearly half of patients who failed to reach the approved 3.0 mg liraglutide ...
Tag: drug affordability
POPULAR NEWS
-
Alloys That Shrink Their Own Grains: New PIX Mechanism Refines Metals With Heat Alone
-
Endurance Exercise Reshapes the Liver in Males and Females Through Distinct Molecular Routes
-
Single Transcription Factor PU.1 Rapidly Converts Fibroblasts into Macrophage-Lineage Cells
-
New Scale Measures How Ready Nurse Educators Really Are for the AI Era